Health and Healthcare

Amgen : AMGN

All Amgen Articles

699 Articles

Jon C. Ogg | Jan 18, 2013 at 9:50 AM EST

Analyst Calls Cancer Treatments Major Biotech Focus in 2013 (AMGN, GSK, ALXN, ARIA, CELG, INCY, ONXX)

ThinkstockThe dread and fear that can come with a cancer diagnosis have their roots in its killer nature. It is…

Jon C. Ogg | Jan 14, 2013 at 10:04 AM EST

More Hope for Cancer Vaccines in 2013 (UBS, GSK, DNDN, AMGN)

ThinkstockCancer ranks on the list of global killers as number two. Over the years, great strides have been made not only…

Jon C. Ogg | Jan 9, 2013 at 7:27 AM EST

The Big Biotech Winners and Losers for 2013 (AMGN, BIIB, CELG, GILD, ALXN, ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

ThinkstockBig biotech had a stellar 2012. In 2013, though, the large biotech companies may be dwarfed in performance by the…

Jon C. Ogg | Jan 8, 2013 at 2:39 PM EST

Investors Ignore Amgen Earnings Warning Due To R&D Tax-Credit

ThinkstockAmgen Inc. (NASDAQ: AMGN) is holding up better than some investors might have expected after the biotech giant warned about…

Jon C. Ogg | Dec 20, 2012 at 2:57 PM EST

How Overvalued Are the Biggest Biotechs? (AMGN, BIIB, GILD, ALXN)

Jon OggThe largest biotech stocks have been great performers in 2012. The question is whether that can be sustained in…

Paul Ausick | Dec 14, 2012 at 8:09 AM EST

Amgen Shakes Things Up: Dividend Boost, New Chairman, Share Buybacks

ThinkstockBiotech giant Amgen Inc. (NASDAQ: AMGN) made a series of moves after markets closed last night that appear to add…

Jon C. Ogg | Dec 12, 2012 at 8:36 AM EST

Top Analyst Upgrades and Downgrades (ALGN, AMGN, C, DYN, FDX, MFRM, MDLZ, NKE, OPEN, ORCL, POT, MOS, PB, STX, TTWO, TEVA, UA, VOLC, YELP)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Wednesday.…

Trey Thoelcke | Nov 12, 2012 at 8:04 AM EST

Short Interest in Biotech Remains Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

ThinkstockWe have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ:…

Jon C. Ogg | Nov 6, 2012 at 6:20 AM EST

Five Big Dividend Hikes Expected Very Soon

ThinkstockDividend stocks may have come under some pressure of late, but this is due to the demand for high dividends…

Trey Thoelcke | Oct 25, 2012 at 7:41 AM EDT

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ:…

Paul Ausick | Oct 24, 2012 at 4:05 PM EDT

24/7 Wall St. Closing Bell — October 24, 2012: Markets Can’t Hold Morning Gains (BUD, NOK, CHKP, AAPL, DLTR, AMGN, BRCM, FB, JNPR, NFLX, T, BA, GLW, LLY, EMC, GD, LCC, ANGI, CLF, CROX, FFIV, RRC, RYL, AET, ZNGA, ALK, AN, BG, CL, DNKN, NOV, POT, UAL, RF, TPX, ZZ, ATI)

The three major U.S. stock indexes opened higher this morning following a better-than-expected PMI reading from China (more coverage here)…

Paul Ausick | Oct 23, 2012 at 4:03 PM EDT

24/7 Wall St. Closing Bell — October 23, 2012: Markets Follow Earnings Lower (BTU, BHI, P, YHOO, MNST, CE, WDC, TXN, MMM, ARMH, AKS, COH, HOG, RSH, UPS, UTX, XRX, AMGN, BRCM, FB, JNPR, NFLX, T, BA, GLW, DAL, LLY, EMC, GD, LCC, DD, BSDM)

The three major U.S. stock indexes opened lower this morning and remained in negative territory all day. The decline is…

Jon C. Ogg | Oct 23, 2012 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades (AMCX, AMGN, BHI, CPST, CHKP, DUK, EIX, MNST, NTAP, OSG, P, PHI, BTU, WDC, YHOO, BKCC, FSC, QLYS, MCC, PNNT)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research notes this Tuesday.…

Jon C. Ogg | Oct 17, 2012 at 12:45 PM EDT

Brand Death of Lance Armstrong, Literally Billions of Dollars At Stake

If the brand of Lance Armstrong was a stock, let’s just be nice say that the value would have tanked.…

Trey Thoelcke | Oct 11, 2012 at 8:25 AM EDT

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

The short interest in biotech stocks is mixed, judging by the short interest changes between the September 14 and September…

1 … 33 34 35 36 37 … 47

Amgen : AMGN

All Amgen Articles

Analyst Calls Cancer Treatments Major Biotech Focus in 2013 (AMGN, GSK, ALXN, ARIA, CELG, INCY, ONXX)

More Hope for Cancer Vaccines in 2013 (UBS, GSK, DNDN, AMGN)

The Big Biotech Winners and Losers for 2013 (AMGN, BIIB, CELG, GILD, ALXN, ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

Investors Ignore Amgen Earnings Warning Due To R&D Tax-Credit

How Overvalued Are the Biggest Biotechs? (AMGN, BIIB, GILD, ALXN)

Amgen Shakes Things Up: Dividend Boost, New Chairman, Share Buybacks

Top Analyst Upgrades and Downgrades (ALGN, AMGN, C, DYN, FDX, MFRM, MDLZ, NKE, OPEN, ORCL, POT, MOS, PB, STX, TTWO, TEVA, UA, VOLC, YELP)

Short Interest in Biotech Remains Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Five Big Dividend Hikes Expected Very Soon

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

24/7 Wall St. Closing Bell — October 24, 2012: Markets Can’t Hold Morning Gains (BUD, NOK, CHKP, AAPL, DLTR, AMGN, BRCM, FB, JNPR, NFLX, T, BA, GLW, LLY, EMC, GD, LCC, ANGI, CLF, CROX, FFIV, RRC, RYL, AET, ZNGA, ALK, AN, BG, CL, DNKN, NOV, POT, UAL, RF, TPX, ZZ, ATI)

24/7 Wall St. Closing Bell — October 23, 2012: Markets Follow Earnings Lower (BTU, BHI, P, YHOO, MNST, CE, WDC, TXN, MMM, ARMH, AKS, COH, HOG, RSH, UPS, UTX, XRX, AMGN, BRCM, FB, JNPR, NFLX, T, BA, GLW, DAL, LLY, EMC, GD, LCC, DD, BSDM)

Top Analyst Upgrades and Downgrades (AMCX, AMGN, BHI, CPST, CHKP, DUK, EIX, MNST, NTAP, OSG, P, PHI, BTU, WDC, YHOO, BKCC, FSC, QLYS, MCC, PNNT)

Brand Death of Lance Armstrong, Literally Billions of Dollars At Stake

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Amgen : AMGN

All Amgen Articles

Analyst Calls Cancer Treatments Major Biotech Focus in 2013 (AMGN, GSK, ALXN, ARIA, CELG, INCY, ONXX)

More Hope for Cancer Vaccines in 2013 (UBS, GSK, DNDN, AMGN)

The Big Biotech Winners and Losers for 2013 (AMGN, BIIB, CELG, GILD, ALXN, ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

Investors Ignore Amgen Earnings Warning Due To R&D Tax-Credit

How Overvalued Are the Biggest Biotechs? (AMGN, BIIB, GILD, ALXN)

Amgen Shakes Things Up: Dividend Boost, New Chairman, Share Buybacks

Top Analyst Upgrades and Downgrades (ALGN, AMGN, C, DYN, FDX, MFRM, MDLZ, NKE, OPEN, ORCL, POT, MOS, PB, STX, TTWO, TEVA, UA, VOLC, YELP)

Short Interest in Biotech Remains Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Five Big Dividend Hikes Expected Very Soon

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

24/7 Wall St. Closing Bell — October 24, 2012: Markets Can’t Hold Morning Gains (BUD, NOK, CHKP, AAPL, DLTR, AMGN, BRCM, FB, JNPR, NFLX, T, BA, GLW, LLY, EMC, GD, LCC, ANGI, CLF, CROX, FFIV, RRC, RYL, AET, ZNGA, ALK, AN, BG, CL, DNKN, NOV, POT, UAL, RF, TPX, ZZ, ATI)

24/7 Wall St. Closing Bell — October 23, 2012: Markets Follow Earnings Lower (BTU, BHI, P, YHOO, MNST, CE, WDC, TXN, MMM, ARMH, AKS, COH, HOG, RSH, UPS, UTX, XRX, AMGN, BRCM, FB, JNPR, NFLX, T, BA, GLW, DAL, LLY, EMC, GD, LCC, DD, BSDM)

Top Analyst Upgrades and Downgrades (AMCX, AMGN, BHI, CPST, CHKP, DUK, EIX, MNST, NTAP, OSG, P, PHI, BTU, WDC, YHOO, BKCC, FSC, QLYS, MCC, PNNT)

Brand Death of Lance Armstrong, Literally Billions of Dollars At Stake

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do